Cite
MLA Citation
Robbe Van den Begin et al.. “The METABANK score: A clinical tool to predict survival after stereotactic radiotherapy for oligometastatic disease.” Radiotherapy and oncology, vol. 133, 2019, pp. 113–119. http://access.bl.uk/ark:/81055/vdc_100079602226.0x00004c